Exploiting the CRISPR/Cas9 system to study alternative splicing in vivo: Application to titin

Human Molecular Genetics

Volumn 25, Issue 20, 2016, Pages 4518-4532

  Charton, Karine ^a,b   Suel, Laurence ^a,b   Henriques, Sara F ^a,b,c   Moussu, Jean Paul ^d   Bovolenta, Matteo ^e   Taillepierre, Miguel ^d   Becker, Céline ^d   Lipson, Karelia ^d   Richard, Isabelle ^a,b  

^a INTEGRARE Research Unit ^*  (France)

^b GÉNÉTHON   (France)

^c UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

^d SEAT SErvice des Animaux Transgéniques CNRS TAAM phenomin UPS44 Bâtiment G 7 ^*  (France)

^e UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIN; ISOPROTEIN; PROTEIN KINASE; TITIN PROTEIN, MOUSE;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRISPR CAS SYSTEM; EMBRYO; FEMALE; GENE EDITING; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANIMAL MODEL; GENETICS; MALE; METABOLISM; PROCEDURES; SARCOMERE;

ALTERNATIVE SPLICING; ANIMALS; CRISPR-CAS SYSTEMS; GENE EDITING; MALE; MICE; MODELS, ANIMAL; PROTEIN ISOFORMS; PROTEIN KINASES; SARCOMERES;

EID: 85014359702     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddw280     Document Type: Article

References (67)

1. Pan, Q., Shai, O., Lee, L.J., Frey, B.J. and Blencowe, B.J. (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet., 40, 1413-1415.
2. Wang, E.T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S.F., Schroth, G.P. and Burge, C.B. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature, 456, 470-476.
3. Modrek, B. and Lee, C. (2002) A genomic view of alternative splicing. Nat Genet, 30, 13-19.
4. Tress, M.L., Martelli, P.L., Frankish, A., Reeves, G.A., Wesselink, J.J., Yeats, C., Olason, P.I., Albrecht, M., Hegyi, H., Giorgetti, A., et al. (2007) The implications of alternative splicing in the ENCODE protein complement. Proc. Natl Acad. Sci. U S A, 104, 5495-5500.
5. Frankish, A., Mudge, J.M., Thomas, M. and Harrow, J. (2012) The importance of identifying alternative splicing in vertebrate genome annotation. Database (Oxford), 2012, bas014.
6. Takeda, J., Suzuki, Y., Sakate, R., Sato, Y., Gojobori, T., Imanishi, T. and Sugano, S. (2010) H-DBAS: humantranscriptome database for alternative splicing: update 2010. Nucleic Acids Res., 38, D86-D90.
7. Lee, J.S., Kallehauge, T.B., Pedersen, L.E. and Kildegaard, H.F. (2015) Site-specific integration in CHO cells mediated by CRISPR/Cas9 and homology-directed DNA repair pathway. Sci. Rep., 5, 8572.
8. Maniatis, T. and Tasic, B. (2002) Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature, 418, 236-243.
9. Breitbart, R.E., Andreadis, A. and Nadal-Ginard, B. (1987) Alternative splicing: a ubiquitous mechanism for the generation of multiple protein isoforms from single genes. Annu. Rev. Biochem., 56, 467-495.
10. Mele, M., Ferreira, P.G., Reverter, F., DeLuca, D.S., Monlong, J., Sammeth, M., Young, T.R., Goldmann, J.M., Pervouchine, D.D., Sullivan, T.J., et al. (2015) Human genomics. The human transcriptome across tissues and individuals. Science, 348, 660-665.
11. Chabot, B. and Shkreta, L. (2016) Defective control of premessenger RNA splicing in human disease. J. Cell Biol., 212, 13-27.
12. Bang, M.L., Centner, T., Fornoff, F., Geach, A.J., Gotthardt, M., McNabb, M., Witt, C.C., Labeit, D., Gregorio, C.C., Granzier, H., et al. (2001) The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system. Circ. Res., 89, 1065-1072.
13. Jackel, M., Witt, C., Antonova, O., Curdt, I., Labeit, S. and Jockusch, H. (1997) Deletion in the Z-line region of the titin gene in a baby hamster kidney cell line, BHK-21-Bi. FEBS Lett., 408, 21-24.
14. Labeit, S. and Kolmerer, B. (1995) Titins: giant proteins in charge of muscle ultrastructure and elasticity. Science, 270, 293-296.
15. Gregorio, C.C., Trombitas, K., Centner, T., Kolmerer, B., Stier, G., Kunke, K., Suzuki, K., Obermayr, F., Herrmann, B., Granzier, H., et al. (1998) The NH2 terminus of titin spans the Z-disc: its interaction with a novel 19-kD ligand (T-cap) is required for sarcomeric integrity. J. Cell Biol., 143, 1013-1027.
16. Obermann, W.M., Gautel, M., Weber, K. and Furst, D.O. (1997) Molecular structure of the sarcomeric M band: mapping of titin and myosin binding domains in myomesin and the identification of a potential regulatory phosphorylation site in myomesin. Embo J., 16, 211-220.
17. Cazorla, O., Freiburg, A., Helmes, M., Centner, T., McNabb, M., Wu, Y., Trombitas, K., Labeit, S. and Granzier, H. (2000) Differential expression of cardiac titin isoforms and modulation of cellular stiffness. Circ. Res., 86, 59-67.
18. Labeit, S., Lahmers, S., Burkart, C., Fong, C., McNabb, M., Witt, S., Witt, C., Labeit, D. and Granzier, H. (2006) Expression of distinct classes of titin isoforms in striated and smooth muscles by alternative splicing, and their conserved interaction with filamins. J. Mol. Biol., 362, 664-681.
19. Neagoe, C., Opitz, C.A., Makarenko, I. and Linke, W.A. (2003) Gigantic variety: expression patterns of titin isoforms in striated muscles and consequences for myofibrillar passive stiffness. J. Muscle Res. Cell Motil., 24, 175-189.
20. Kolmerer, B., Olivieri, N., Witt, C.C., Herrmann, B.G. and Labeit, S. (1996) Genomic organization of M line titin and its tissue-specific expression in two distinct isoforms. J. Mol. Biol., 256, 556-563.
21. Guo, W., Bharmal, S.J., Esbona, K. and Greaser, M.L. (2010) Titin diversity-alternative splicing gone wild. J. Biomed. Biotechnol., 2010, 753675.
22. Duguez, S., Bartoli, M. and Richard, I. (2006) Calpain 3: a key regulator of the sarcomere? Febs J., 273, 3427-3436.
23. Richard, I., Broux, O., Allamand, V., Fougerousse, F., Chiannilkulchai, N., Bourg, N., Brenguier, L., Devaud, C., Pasturaud, P., Roudaut, C., et al. (1995) Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell, 81, 27-40.
24. Charton, K., Daniele, N., Vihola, A., Roudaut, C., Gicquel, E., Monjaret, F., Tarrade, A., Sarparanta, J., Udd, B. and Richard, I. (2010) Removal of the calpain 3 protease reverses the myopathology in a mouse model for titinopathies. Hum. Mol. Genet., 19, 4608-4624.
25. Charton, K., Sarparanta, J., Vihola, A., Milic, A., Jonson, P.H., Suel, L., Luque, H., Boumela, I., Richard, I. and Udd, B. (2015) CAPN3-mediated processing of C-terminal titin replaced by pathological cleavage in titinopathy. Hum. Mol. Genet., 24, 3718-3731.
26. Sarparanta, J., Blandin, G., Charton, K., Vihola, A., Marchand, S., Milic, A., Hackman, P., Ehler, E., Richard, I. and Udd, B. (2010) Interactions with M-band titin and calpain 3 link myospryn (CMYA5) to tibial and limb-girdle muscular dystrophies. J. Biol. Chem., 285, 30304-30315.
27. Ojima, K., Kawabata, Y., Nakao, H., Nakao, K., Doi, N., Kitamura, F., Ono, Y., Hata, S., Suzuki, H., Kawahara, H., et al. (2010) Dynamic distribution of muscle-specific calpain in mice has a key role in physical-stress adaptation and is impaired in muscular dystrophy. J. Clin. Invest., 120, 2672-2683.
28. Ojima, K., Ono, Y., Hata, S., Koyama, S., Doi, N. and Sorimachi, H. (2005) Possible functions of p94 in connectinmediated signaling pathways in skeletal muscle cells. J. Muscle. Res. Cell Motil, 26, 409-417.
29. Beckmann, J.S. and Spencer, M. (2008) Calpain 3, the "gatekeeper" of proper sarcomere assembly, turnover and maintenance. Neuromuscul. Disord., 18, 913-921.
30. Ono, Y., Torii, F., Ojima, K., Doi, N., Yoshioka, K., Kawabata, Y., Labeit, D., Labeit, S., Suzuki, K., Abe, K., et al. (2006) Suppressed disassembly of autolyzing p94/CAPN3 by N2A connectin/titin in a genetic reporter system. J. Biol. Chem., 281, 18519-18531.
31. Sorimachi, H., Kinbara, K., Kimura, S., Takahashi, M., Ishiura, S., Sasagawa, N., Sorimachi, N., Shimada, H., Tagawa, K., Maruyama, K., et al. (1995) Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence. J. Biol. Chem., 270, 31158-31162.
32. Hackman, P., Marchand, S., Sarparanta, J., Vihola, A., Penisson-Besnier, I., Eymard, B., Pardal-Fernandez, J.M., Hammouda el, H., Richard, I., Illa, I., et al. (2008) Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD). Neuromuscul. Disord., 18, 922-928.
33. Lin, X., Miller, J.W., Mankodi, A., Kanadia, R.N., Yuan, Y., Moxley, R.T., Swanson, M.S. and Thornton, C.A. (2006) Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet., 15, 2087-2097.
34. Kinbara, K., Sorimachi, H., Ishiura, S. and Suzuki, K. (1997) Muscle-specific calpain, p94, interacts with the extreme Cterminal region of connectin, a unique region flanked by two immunoglobulin C2 motifs. Arch. Biochem. Biophys., 342, 99-107.
35. Fu, Y., Reyon, D. and Joung, J.K. (2014) Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs. Methods Enzymol., 546, 21-45.
36. Yang, H., Wang, H. and Jaenisch, R. (2014) Generating genetically modified mice using CRISPR/Cas-mediated genome engineering. Nat. Protoc., 9, 1956-1968.
37. Greco, S., De Simone, M., Colussi, C., Zaccagnini, G., Fasanaro, P., Pescatori, M., Cardani, R., Perbellini, R., Isaia, E., Sale, P., et al. (2009) Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. Faseb J., 23, 3335-3346.
38. Fordham, J.B., Naqvi, A.R. and Nares, S. (2015) Regulation of miR-24, miR-30b, and miR-142-3p during macrophage and dendritic cell differentiation potentiates innate immunity. J. Leukoc. Biol., 98, 195-207.
39. Radke, M.H., Peng, J., Wu, Y., McNabb, M., Nelson, O.L., Granzier, H. and Gotthardt, M. (2007) Targeted deletion of titin N2B region leads to diastolic dysfunction and cardiac atrophy. Proc. Natl Acad. Sci. U S A, 104, 3444-3449.
40. Granzier, H.L., Radke, M.H., Peng, J., Westermann, D., Nelson, O.L., Rost, K., King, N.M., Yu, Q., Tschope, C., McNabb, M., et al. (2009) Truncation of titin's elastic PEVK region leads to cardiomyopathy with diastolic dysfunction. Circ. Res., 105, 557-564.
41. Parra, M.K., Gee, S., Mohandas, N. and Conboy, J.G. (2011) Efficient in vivo manipulation of alternative pre-mRNA splicing events using antisense morpholinos in mice. J. Biol. Chem., 286, 6033-6039.
42. Fugier, C., Klein, A.F., Hammer, C., Vassilopoulos, S., Ivarsson, Y., Toussaint, A., Tosch, V., Vignaud, A., Ferry, A., Messaddeq, N., et al. (2011) Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nat. Med., 17, 720-725.
43. Rau, F., Laine, J., Ramanoudjame, L., Ferry, A., Arandel, L., Delalande, O., Jollet, A., Dingli, F., Lee, K.Y., Peccate, C., et al. (2015) Abnormal splicing switch of DMD's penultimate exon compromises muscle fibre maintenance in myotonic dystrophy. Nat. Commun., 6, 7205.
44. Huang, C., Zhou, Q., Liang, P., Hollander, M.S., Sheikh, F., Li, X., Greaser, M., Shelton, G.D., Evans, S. and Chen, J. (2003) Characterization and in vivo functional analysis of splice variants of cypher. J. Biol. Chem., 278, 7360-7365.
45. Spencer, M.J., Guyon, J.R., Sorimachi, H., Potts, A., Richard, I., Herasse, M., Chamberlain, J., Dalkilic, I., Kunkel, L.M. and Beckmann, J.S. (2002) Stable expression of calpain 3 from a muscle transgene in vivo: immature muscle in transgenic mice suggests a role for calpain 3 in muscle maturation. Proc. Natl Acad. Sci.U S A, 99, 8874-8879.
46. Guo, W., Schafer, S., Greaser, M.L., Radke, M.H., Liss, M., Govindarajan, T., Maatz, H., Schulz, H., Li, S., Parrish, A.M., et al. (2012) RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat. Med., 18, 766-773.
47. Dixon, D.M., Choi, J., El-Ghazali, A., Park, S.Y., Roos, K.P., Jordan, M.C., Fishbein, M.C., Comai, L. and Reddy, S. (2015) Loss of muscleblind-like 1 results in cardiac pathology and persistence of embryonic splice isoforms. Sci. Rep., 5, 9042.
48. Wang, H., Yang, H., Shivalila, C.S., Dawlaty, M.M., Cheng, A.W., Zhang, F. and Jaenisch, R. (2013) One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell, 153, 910-918.
49. Fujii, W., Onuma, A., Sugiura, K. and Naito, K. (2014) Onestep generation of phenotype-expressing triple-knockout mice with heritable mutated alleles by the CRISPR/Cas9 system. J. Reprod. Dev., 60, 324-327.
50. Young, C.S., Hicks, M.R., Ermolova, N.V., Nakano, H., Jan, M., Younesi, S., Karumbayaram, S., Kumagai-Cresse, C., Wang, D., Zack, J.A., et al. (2016) A single CRISPR-Cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells. Cell Stem Cell, in press.
51. Slaymaker, I.M., Gao, L., Zetsche, B., Scott, D.A., Yan, W.X. and Zhang, F. (2016) Rationally engineered Cas9 nucleases with improved specificity. Science, 351, 84-88.
52. Kleinstiver, B.P., Pattanayak, V., Prew, M.S., Tsai, S.Q., Nguyen, N.T., Zheng, Z. and Joung, J.K. (2016) High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature, 529, 490-495.
53. Udd, B. (1992) Limb-girdle type muscular dystrophy in a large family with distal myopathy: homozygous manifestation of a dominant gene? J. Med. Genet., 29, 383-389.
54. Erickson, H.P. (1994) Reversible unfolding of fibronectin type III and immunoglobulin domains provides the structural basis for stretch and elasticity of titin and fibronectin. Proc. Natl Acad. Sci. U S Aa, 91, 10114-10118.
55. Sjostrom, M. and Squire, J.M. (1977) Fine structure of the Aband in cryo-sections. The structure of the A-band of human skeletal muscle fibres from ultra-thin cryo-sections negatively stained. J. Mol. Biol., 109, 49-68.
56. Edman, A.C., Squire, J.M. and Sjostrom, M. (1988) Fine structure of the A-band in cryo-sections. Diversity of M-band structure in chicken breast muscle. J. Ultrastruct. Mol. Struct. Res., 100, 1-12.
57. Podlubnaya, Z.A., Shpagina, M.D. and Lednev, V.V. (1989) Manifestation of the stripes of minor proteins location in Abands of rabbit cardiac myofibrils. J. Mol. Biol., 210, 655-658.
58. Carlsson, E. and Thornell, L.E. (1987) Diversification of the myofibrillar M-band in rat skeletal muscle during postnatal development. Cell Tissue Res., 248, 169-180.
59. Herasse, M., Ono, Y., Fougerousse, F., Kimura, E., Stockholm, D., Beley, C., Montarras, D., Pinset, C., Sorimachi, H., Suzuki, K., et al. (1999) Expression and functional characteristics of calpain 3 isoforms generated through tissue-specific transcriptional and posttranscriptional events. Mol. Cell Biol., 19, 4047-4055.
60. Hayashi, C., Ono, Y., Doi, N., Kitamura, F., Tagami, M., Mineki, R., Arai, T., Taguchi, H., Yanagida, M., Hirner, S., et al. (2008) Multiple molecular interactions implicate the connectin/titin N2A region as a modulating scaffold for p94/calpain 3 activity in skeletal muscle. J. Biol. Chem., 283, 14801-14814.
61. Laure, L., Suel, L., Roudaut, C., Bourg, N., Ouali, A., Bartoli, M., Richard, I. and Daniele, N. (2009) Cardiac ankyrin repeat protein is a marker of skeletal muscle pathological remodelling. Febs J., 276, 669-684.
62. Sander, J.D., Zaback, P., Joung, J.K., Voytas, D.F. and Dobbs, D. (2007) Zinc Finger Targeter (ZiFiT): an engineered zinc finger/target site design tool. Nucleic Acids Res., 35, W599-W605.
63. Sander, J.D., Maeder, M.L., Reyon, D., Voytas, D.F., Joung, J.K. and Dobbs, D. (2010) ZiFiT (Zinc Finger Targeter): an updated zinc finger engineering tool. Nucleic Acids Res., 38, W462-W468.
64. Wang, T., Wei, J.J., Sabatini, D.M. and Lander, E.S. (2014) Genetic screens in human cells using the CRISPR-Cas9 system. Science, 343, 80-84.
65. Jinek, M., East, A., Cheng, A., Lin, S., Ma, E. and Doudna, J. (2013) RNA-programmed genome editing in human cells. Elife, 2, e00471.
66. Monjaret, F., Bourg, N., Suel, L., Roudaut, C., Le Roy, F, Richard, I. and Charton, K., (2014) CIS-splicing and translation of the pre-trans-splicing molecule combine with efficiency in spliceosome-mediated RNA trans-splicing. Mol Ther, 22, 1176-1187.
67. Holkers, M., Cathomen, T. and Goncalves, M.A. (2014) Construction and characterization of adenoviral vectors for the delivery of TALENs into human cells. Methods, 69, 179-187.